Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine

Abstract

Nanovaccines have emerged as promising agents for cancer immunotherapy. However, insufficient antitumor immunity caused by inefficient antigen/adjuvant loading and complicated preparation processes are the major obstacles that limit their clinical application. Herein, two adjuvants, monophosphatidyl A (MPLA) and CpG ODN, with antigens were designed into a nanovaccine to overcome the above obstacles. This nanovaccine was constructed with adjuvants (without additional materials) through facile self-assembly, which not only ensured a high loading efficacy and desirable safety but also facilitated clinical translation for convenient fabrication. More importantly, the selected adjuvants could achieve a notable immune response through synergistic activation of Toll-like receptor 4 (TLR4) and TLR9 signaling pathways, and the resulting nanovaccine remarkably inhibited the tumor growth and prolonged the survival of tumor-implanted mice. This nanovaccine system provides an effective strategy to construct vaccines for cancer immunotherapy.

Solution-Phase Synthesis of DNA Amphiphiles for DNA Micellar Assembly

“…The method allows convenient synthesis of amphiphilic DNAs with various DNA sequence, length, modification location, and modification identity. This development, we believe, would facilitate detailed investigation of amphiphilic DNA assembly, which could be important for drug delivery and nanoconstruction. ,− …”

Engineered bacteria for augmentedin situtumor vaccination

“…Compared to other intratumoral immunotherapies including TLR agonist, glucan, cytokine, or nanoparticle-based formulations, bacteria as 'living therapeutic platforms' can proliferate in the hypoxic tumor regions and produce targeted-gene encoded therapeutic agents within tumor sites, which could improve the local concentration of drugs continuously for augmented therapeutic efficacy. [73][74][75] In addition, bacteria comprise diverse PAMP molecules like polysaccharides and nucleic acids, which can activate a broad class of innate-sensing signaling pathways to sensitize the tumor microenvironment. However, direct intravenous injection of bacteria may induce sepsis and can cause death.…”

Plant-derived nanovesicles as an emerging platform for cancer therapy

“…Fueled by the advances in biotechnology and materials science, nanotechnologies have been widely investigated for cancer treatment, aiming to enhance safety, accuracy, and efficacy by leveraging the unique properties of engineered nanomaterials 20 , 21 . These materials are usually designed in the form of nano- and/or microparticles to alter the biodistribution and pharmacokinetics of the therapeutic agents they are linked with, or to serve as drug reservoirs, or both 22 , 23 .…”